Clinically, patients with PD with GBA1 variants show an earlier age at onset, more rapid disease progression, and higher rates of nonmotor symptoms, such as rapid eye movement sleep behavior disorder (RBD) and cognitive impairment, compared with those with non-GBA1–associated PD (14–16). This evidence concerns the gene GBA1 and Cognitive impairment.